BioSpace News Archive

Intellia Therapeutics, Inc. today reported operational highlights and financial results for the second quarter ended June 30, 2022.

KemPharm, Inc. today announced that the Company will host a conference call and live audio webcast on Thursday, August 11, 2022, at 5:00 p.m. ET, to discuss its corporate and financial results for the second quarter 2022.

Arbutus Biopharma Corporation today reports its second quarter 2022 financial results and provides corporate updates.

The tissue microarray market has been anticipated to grow at a significant speed in the years to come.

Wilmington, Delaware, United States, Transparency Market Research Inc.: According to the report, the global glioblastoma multiforme treatment market was valued at US$ 1.61 Bn in 2020 and is projected to expand at a CAGR of 8.1% from 2021 to 2028.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global medical transcription services market for the historical period 2017–2019 and forecast period 2021–2028, increase in healthcare automation and rise in emphasis on using standard reporting styles are projected to drive the global medical transcription services market during the forecast period.

Wilmington, Delaware, United States, Transparency Market Research Inc.: According to the report, the global healthcare biometrics market was valued at US$ 22.92 Bn in 2020.

The molecular biology enzymes, kits, and reagents market has been predicted to grow at a significant speed in the incoming years.

Wilmington, Delaware, United States, Transparency Market Research Inc.: There are various ways in which established players are trying to increase their stronghold over the global market for nanoemulsion.

UNION therapeutics A/S announces that the first patient has been enrolled in ADESOS, a Phase 2b dose-finding study evaluating the safety and efficacy of orismilast MR tablet in adult patients with moderate to severe AD.